世界の心臓再同期療法(CRT)市場2021-2027:製品種類別(心臓再同期型治療除細動器、心臓再同期型治療ペースメーカー)、エンドユーザー別、地域別

調査会社Bizwit Research & Consulting社が発行したリサーチレポート(データ管理コード:BZW21JN040)
◆英語タイトル:Global Cardiac Resynchronization Therapy Market Size study, by Product type (Cardiac Resynchronized Therapy Defibrillators, Cardiac Resynchronized Therapy Pacemakers), by End User (Hospitals & Cardiac Centers, Ambulatory Surgery Centers) and Regional Forecasts 2021-2027
◆発行会社/調査会社:Bizwit Research & Consulting
◆商品コード:BZW21JN040
◆発行日:2021年5月25日
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆産業分野:医薬品
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の心臓再同期療法(CRT)市場2021-2027:製品種類別(心臓再同期型治療除細動器、心臓再同期型治療ペースメーカー)、エンドユーザー別、地域別]についてメールでお問い合わせはこちら
本調査レポートでは、世界の心臓再同期療法(CRT)市場について調査・分析を行い、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品種類別(除細動器、ペースメーカー)分析、エンドユーザー別(病院&心臓センター、外来手術センター)分析、地域別分析、競争状況、調査プロセスなどの項目を掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の心臓再同期療法(CRT)市場規模:製品種類別(除細動器、ペースメーカー)
・世界の心臓再同期療法(CRT)市場規模:エンドユーザー別(病院&心臓センター、外来手術センター)
・世界の心臓再同期療法(CRT)市場規模:地域別
・競争状況
・調査プロセス
*** レポート概要(サマリー)***

Global Cardiac Resynchronization Therapy Market is valued approximately at USD 4.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.4% over the forecast period 2021-2027. The major factors contributing to the growth of the CRT market are rising incidences of cardiac disorders and heart failure and shift towards a sedentary lifestyle among the population. The rise in geriatric population due to increased life expectancy is also fueling the market growth. According to the data of United Nations, the number of persons aged above 65 years was estimated to be 727 million in 2020 and the number is projected to be more than double by 2050. Also, the percentage of older people among the global population is anticipated to increase from 9.3 percent in 2020 to 16 percent in 2050. Furthermore, technological advancements and new emerging markets are likely to open up new opportunities for the market. However, lack of skilled professionals and high device replacement cost may hinder the growth of the market over the forecast period.

The regional analysis of global Cardiac Resynchronization Therapy Market is based on key regions including Asia Pacific, Europe, North America, Latin America, and the rest of the world. North America is dominating the market in terms of share and is also expected to exhibit the highest CAGR over the forecast period. This growth can be attributed to the growing healthcare expenditure, and the advent of new technological advancements in the region.

Major market player included in this report are:

Medtronic, PLC.
Abbott Laboratories
Boston Scientific Corporation
Biotronik
Medico S.P.A.
MicroPort Scientific Corporation
St. Jude Medical
LivaNova Plc
Lepu Medical Technology Co. Ltd.
Shree Pacetronix Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Cardiac Resynchronized Therapy Defibrillators
Cardiac Resynchronized Therapy Pacemakers

By End User:
Hospitals & Cardiac Centers
Ambulatory Surgery Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Cardiac Resynchronization Therapy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

*** レポート目次(コンテンツ)***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Cardiac Resynchronization Therapy Market, by Region, 2019-2027 (USD Billion)
1.2.2. Cardiac Resynchronization Therapy Market, by Product Type, 2019-2027 (USD Billion)
1.2.3. Cardiac Resynchronization Therapy Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Resynchronization Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Resynchronization Therapy Market Dynamics
3.1. Cardiac Resynchronization Therapy Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing geriatric population
3.1.1.2. Rising incidence of target diseases
3.1.2. Market Restraint
3.1.2.1. Battery life and device replacement cost
3.1.2.2. Shortage of skilled cardiac surgeons
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Emerging markets
Chapter 4. Global Cardiac Resynchronization Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Resynchronization Therapy Market, by Product Type
a. Market Snapshot
5.1. Global Cardiac Resynchronization Therapy Market by Product Type, Performance – Potential Analysis
5.2. Global Cardiac Resynchronization Therapy Market Estimates & Forecasts by Product Type 2018-2027 (USD Billion)
5.3. Cardiac Resynchronization Therapy Market, Sub Segment Analysis
5.3.1. Cardiac Resynchronization Therapy Defibrillators
5.3.2. Cardiac Resynchronization Therapy Pacemakers
Chapter 6. Global Cardiac Resynchronization Therapy Market, by End User
b. Market Snapshot
6.1. Global Cardiac Resynchronization Therapy Market by End User, Performance – Potential Analysis
6.2. Global Cardiac Resynchronization Therapy Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
6.3. Cardiac Resynchronization Therapy Market, Sub Segment Analysis
6.3.1. Hospitals & Cardiac Centers
6.3.2. Ambulatory Surgery Centers
Chapter 7. Global Cardiac Resynchronization Therapy Market, Regional Analysis
7.1. Cardiac Resynchronization Therapy Market, Regional Market Snapshot
7.2. North America Cardiac Resynchronization Therapy Market
7.2.1. U.S. Cardiac Resynchronization Therapy Market
7.2.1.1. Product Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. End User breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Cardiac Resynchronization Therapy Market
7.3. Europe Cardiac Resynchronization Therapy Market Snapshot
7.3.1. U.K. Cardiac Resynchronization Therapy Market
7.3.2. Germany Cardiac Resynchronization Therapy Market
7.3.3. France Cardiac Resynchronization Therapy Market
7.3.4. Spain Cardiac Resynchronization Therapy Market
7.3.5. Italy Cardiac Resynchronization Therapy Market
7.3.6. Rest of Europe Cardiac Resynchronization Therapy Market
7.4. Asia-Pacific Cardiac Resynchronization Therapy Market Snapshot
7.4.1. China Cardiac Resynchronization Therapy Market
7.4.2. India Cardiac Resynchronization Therapy Market
7.4.3. Japan Cardiac Resynchronization Therapy Market
7.4.4. Australia Cardiac Resynchronization Therapy Market
7.4.5. South Korea Cardiac Resynchronization Therapy Market
7.4.6. Rest of Asia Pacific Cardiac Resynchronization Therapy Market
7.5. Latin America Cardiac Resynchronization Therapy Market Snapshot
7.5.1. Brazil Cardiac Resynchronization Therapy Market
7.5.2. Mexico Cardiac Resynchronization Therapy Market
7.6. Rest of The World Cardiac Resynchronization Therapy Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Medtronic, PLC.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Abbott Laboratories
8.2.3. Boston Scientific Corporation
8.2.4. Biotronik
8.2.5. Medico S.P.A.
8.2.6. Microport Scientific Corporation
8.2.7. St. Jude Medical
8.2.8. LivaNova Plc
8.2.9. Lepu Medical Technology Co. Ltd.
8.2.10. Shree Pacetronix Ltd.

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 2. Global Cardiac Resynchronization Therapy Market, report scope
TABLE 3. Global Cardiac Resynchronization Therapy Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Cardiac Resynchronization Therapy Market estimates & forecasts by Product Type 2018-2027 (USD Billion)
TABLE 5. Global Cardiac Resynchronization Therapy Market estimates & forecasts by End User 2018-2027 (USD Billion)
TABLE 6. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. U.S. Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Canada Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Canada Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Canada Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. UK Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. UK Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. UK Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. Germany Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. Germany Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. Germany Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. France Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. France Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. France Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Spain Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Spain Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Spain Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Italy Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. Italy Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Italy Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. ROE Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. ROE Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. ROE Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. China Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. China Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. China Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. India Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. India Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. India Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Japan Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Japan Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Japan Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Australia Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 56. Australia Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. Australia Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. South Korea Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 59. South Korea Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. South Korea Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. ROPAC Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 62. ROPAC Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. ROPAC Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. Brazil Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 65. Brazil Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Brazil Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Mexico Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 68. Mexico Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. Mexico Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. ROLA Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 71. ROLA Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROLA Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROW Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 74. ROW Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. ROW Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. List of secondary sources used in the study of global Cardiac Resynchronization Therapy Market.
TABLE 77. List of primary sources used in the study of global Cardiac Resynchronization Therapy Market.
TABLE 78. Years considered for the study.
TABLE 79. Exchange rates considered.

List of figures
FIG 1. Global Cardiac Resynchronization Therapy Market, research methodology
FIG 2. Global Cardiac Resynchronization Therapy Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cardiac Resynchronization Therapy Market, key trends 2020
FIG 5. Global Cardiac Resynchronization Therapy Market, growth prospects 2021-2027
FIG 6. Global Cardiac Resynchronization Therapy Market, porters 5 force model
FIG 7. Global Cardiac Resynchronization Therapy Market, pest analysis
FIG 8. Global Cardiac Resynchronization Therapy Market, value chain analysis
FIG 9. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Cardiac Resynchronization Therapy Market, regional snapshot 2018 & 2027
FIG 18. North America Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
FIG 19. Europe Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
FIG 22. Global Cardiac Resynchronization Therapy Market, company market share analysis (2020)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BZW21JN040 )"世界の心臓再同期療法(CRT)市場2021-2027:製品種類別(心臓再同期型治療除細動器、心臓再同期型治療ペースメーカー)、エンドユーザー別、地域別" (英文:Global Cardiac Resynchronization Therapy Market Size study, by Product type (Cardiac Resynchronized Therapy Defibrillators, Cardiac Resynchronized Therapy Pacemakers), by End User (Hospitals & Cardiac Centers, Ambulatory Surgery Centers) and Regional Forecasts 2021-2027)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。